🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial tests the safety and tolerability of an experimental ...
Status
Recruiting
Location
Mayo Clinic in Florida
Start Date
2022-03-31
Trial ID
NCT05269381
This study will find the maximum tolerated dose (MTD) of CYNK-101 which con...
Status
Terminated
Location
Scripps Health
Start Date
2022-04-14
Trial ID
NCT05207722
This phase II trial studies how well pembrolizumab and interferon gamma-1b ...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2017-12-14
Trial ID
NCT03063632
Treatments Being Tested
Researchers want to learn if the study medicines calderasib and subcutaneou...
Status
Recruiting
Location
Central Alabama Research ( Site 0108)
Start Date
2025-10-08
Trial ID
NCT07190248
Treatments Being Tested
Researchers are looking for new ways to treat high-risk, localized non-smal...
Status
Recruiting
Location
UC Davis Comprehensive Cancer Center ( Site 3204)
Start Date
2026-05-04
Trial ID
NCT07513376
Treatments Being Tested
This is a phase I/IIa, two-part, open-label study to characterize the safet...
Status
Terminated
Location
Institute Gustave Roussy
Start Date
2022-05-04
Trial ID
NCT05307874
Treatments Being Tested
This is a multiphase, multicenter study, which includes a Phase 1a open-lab...
Status
Recruiting
Location
HonorHealth Research Institute
Start Date
2021-08-06
Trial ID
NCT04787042
Treatments Being Tested
This phase II/III Lung-MAP trial studies how well immunotherapy treatment w...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham
Start Date
2022-03-15
Trial ID
NCT05096663
The purpose of this study is to assess the safety and tolerability of BJ-00...
Status
Unknown
Location
Washington University School of Medicine
Start Date
2019-12-04
Trial ID
NCT04294576
Treatments Being Tested
This phase I trial evaluates the safety and effectiveness of in situ immuno...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2023-01-09
Trial ID
NCT04616248